PDZD2 anticorps (AA 1-11)
Aperçu rapide pour PDZD2 anticorps (AA 1-11) (ABIN1885573)
Antigène
Voir toutes PDZD2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-11
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Synthetic peptide contain a sequence corresponding to a region within amino acids 1 and 11 (O15018) of PDZK3
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- PDZD2 (PDZ Domain Containing 2 (PDZD2))
-
Autre désignation
- PDZK3
-
Sujet
-
Proteins containing PDZ domains have been shown frequently to bind the C-termini of transmembrane receptors or ion channels.They have also been shown to bind to other PDZ domain proteins and could possibly be involved in intracellular signalling.The protein encoded by this gene contains six PDZ domains and shares sequence similarity with pro-interleukin-16 (pro-IL-16).Like pro-IL-16, the encoded protein localizes to the endoplasmic reticulum and is thought to be cleaved by a caspase to produce a secreted peptide containing two PDZ domains.In addition, this gene is upregulated in primary prostate tumors and may be involved in the early stages of prostate tumorigenesis.[provided by RefSeq]
-
Poids moléculaire
- 302 kDa
-
ID gène
- 23037
-
NCBI Accession
- NM_178140, NP_835260
Antigène
-